FINWIRES · TerminalLIVE
FINWIRES

$QNCX

1 story mentioning QNCXUpdated just now

Every FINWIRES story that references QNCX, newest first.

Research

Cantor Fitzgerald Initiates Quince Therapeutics at Overweight With $4 Price Target

$QNCX

Track with the FINWIRES app suite

FolioX
FolioX
Track QNCX in your portfolio
WheelAI
WheelAI
Analyze QNCX options with the wheel strategy
StockInsider
StockInsider
See market sentiment on QNCX